FindTrial
Sign In

Study on the efficacy of xuanbai chengqi decoction combined with compound lactobacillus in the treatment of sepsis related ARDS

Study on the efficacy of xuanbai chengqi decoction combined with compound lactobacillus in the treatment of sepsis related ARDS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015134
Enrollment
Unknown
Registered
2018-03-09
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis related ARDS

Interventions

Experimental group:xuanbai chengqi decoction combined with compound lactobacillus
The control group:Routine symptomatic treatment

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria of sepsis and ARDS; (2) between the ages of 18 and 75 years;

Exclusion criteria

Exclusion criteria: (1) failure to meet the above two diagnostic criteria and inclusion criteria; (2) for a variety of reasons including death;

Design outcomes

Primary

MeasureTime frame
Blood lactic acid;Blood oxygen partial pressure;—

Countries

China

Contacts

Public ContactTuo Chengde

Gansu Provincial Hospital of Traditional Chinese Medicine

Chengdetuo@163.com+86 15002591792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026